JUAN JOSÉ
TORRADO DURÁN
Profesor titular de universidad
Maria Auxiliadora
Dea Ayuela
Publicaciones en las que colabora con Maria Auxiliadora Dea Ayuela (15)
2023
-
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers
International journal of pharmaceutics, Vol. 635, pp. 122788
2020
-
Evaluating the potential of ursolic acid as bioproduct for cutaneous and visceral leishmaniasis
Molecules, Vol. 25, Núm. 6
2017
-
Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections
Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106
2015
-
Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles
Molecular Pharmaceutics, Vol. 12, Núm. 2, pp. 420-431
2014
-
New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp
International Journal of Pharmaceutics, Vol. 473, Núm. 1-2, pp. 148-157
2013
-
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 38-46
2008
-
Efficacy of alternative dosing regimens of poly-aggregated amphotericin B
International Journal of Antimicrobial Agents, Vol. 32, Núm. 1, pp. 55-61
-
HPLC assay for determination of amphotericin B in biological samples
Biomedical Chromatography, Vol. 22, Núm. 4, pp. 402-407
-
In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation
Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 5, pp. 1125-1131
2007
-
In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum
International Journal of Antimicrobial Agents, Vol. 30, Núm. 4, pp. 325-329
2006
-
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation
Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 4, pp. 1195-1201
2005
-
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B
Journal of Drug Targeting, Vol. 13, Núm. 4, pp. 225-233
2004
-
Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis
Journal of Drug Targeting, Vol. 12, Núm. 7, pp. 453-460
-
Anti-leishmanial activity of a new formulation of amphotericin B
Tropical Medicine and International Health, Vol. 9, Núm. 9, pp. 981-990
-
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres
Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 9, pp. 3246-3252